SP to Grassley: Here's Your Disclosure, Right Here

| | Comments (0) | TrackBacks (0)

Moving through this morning's pharma blogosphere is an AP story describing the responses of some drug or medical-device companies to Senator Chuck Grassley's request that they disclose their CME funding to outside groups. The current industry model is that of Eli Lilly, which provides a highly itemized (and therefore, very difficult-to-synthesize) online grants registry report for each financial quarter of 2007.

Among the companies' soup-to-nuts replies to Grassley:

  • Medtronic will post payments for professional meetings and patient groups on May 1 (no mention of funds to medical communications companies);
  • AstraZeneca will do the same on August 1;
  • Merck is "currently in the process of developing an action plan";
  • Amgen and Abbott have formed "working groups"; and
  • nose-thumbing Schering-Plough reports that it has no plans "at the moment" to publish the requested information.

Today's WSJ Health Blog notes that Grassley's also sponsoring the Physician Payments Sunshine* Act of 2007, which will require quarterly reports from drug or medical-device companies to the DHHS regarding payments made to individual physicians or their employers.

CME = continuing medical education.

*As in, blow sunshine up my...?

0 TrackBacks

Listed below are links to blogs that reference this entry: SP to Grassley: Here's Your Disclosure, Right Here.

TrackBack URL for this entry: http://bmartinmd.com/cgi-bin/mt/mt-tb.cgi/129

Leave a comment

About this Entry

This page contains a single entry by bmartin published on April 11, 2008 10:38 AM.

No Wonder Chinese ED Pills Work Redux was the previous entry in this blog.

Independent Reviewer: ENHANCE Data "Not Acceptable" is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 4.01